5:35 PM
 | 
Aug 06, 2009
 |  BC Extra  |  Company News

Vernalis, GSK in cancer deal

Vernalis plc (LSE:VER) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered to develop a Vernalis research program against an undisclosed cancer target. Vernalis is responsible for drug discovery, while GSK is...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >